{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:15:13Z","timestamp":1770506113671,"version":"3.49.0"},"reference-count":25,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2014,7,2]]},"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The risks of breast cancer associated with <jats:italic>BRCA1<\/jats:italic> and <jats:italic>BRCA2<\/jats:italic> mutations vary considerably across studies but few have assessed prospective risks, which are likely to provide more reliable risk estimates for women undergoing presymptomatic testing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Prospective breast cancer risks were assessed in 254 unaffected women with <jats:italic>BRCA1<\/jats:italic> mutations and 238 with <jats:italic>BRCA2<\/jats:italic> mutations. Rates of breast cancer were calculated allowing for lead time bias and censored at time of risk reducing mastectomy. Degree of family history was assessed using the Manchester score and genotyping was undertaken using 18 single-nucleotide polymorphisms (SNPs) linked to breast cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Nineteen breast cancers occurred in women undergoing presymptomatic testing for <jats:italic>BRCA1<\/jats:italic> and 23 for <jats:italic>BRCA2<\/jats:italic>. Breast cancer incidence for <jats:italic>BRCA2<\/jats:italic> was marginally higher than <jats:italic>BRCA1<\/jats:italic> at 20.05 per 1000 in <jats:italic>BRCA2<\/jats:italic> compared with 16.20 per 1000 in <jats:italic>BRCA1<\/jats:italic>. Penetrance estimates to 70\u2005years of age adjusted for a 6-month lead time and oophorectomy using Kaplan\u2013Meier analysis were 55.1% (95% CI 36.5% to 75.6%) for <jats:italic>BRCA1<\/jats:italic> and 71.5% (95% CI 53.2% to 87.6%). Breast cancer cases were associated with stronger family histories and higher SNP aggregate scores in <jats:italic>BRCA2<\/jats:italic>.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Prospective breast cancer risks in women in the UK are high especially for <jats:italic>BRCA2<\/jats:italic> families ascertained on the basis of high risk. Women undergoing presymptomatic testing for <jats:italic>BRCA2<\/jats:italic> should be quoted a wide range of possible breast cancer risks and should be steered within that range based on degree of family history, non-genetic risk factors and possibly SNP testing.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmedgenet-2014-102336","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T03:39:04Z","timestamp":1406086744000},"page":"573-580","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Long-term prospective clinical follow-up after <i>BRCA1\/2<\/i> presymptomatic testing: <i>BRCA2<\/i> risks higher than in adjusted retrospective studies"],"prefix":"10.1136","volume":"51","author":[{"given":"D Gareth","family":"Evans","sequence":"first","affiliation":[{"name":"Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester NHS Trust, Manchester, UK"},{"name":"Manchester Centre for Genomic Medicine, Central Manchester Foundation Trust, St. Mary's Hospital, Manchester, UK"},{"name":"Manchester Breast Centre, Manchester Cancer Research Centre, University of Manchester, Christie Hospital, Manchester, UK"},{"name":"The University of Manchester, Manchester Academic Health Science Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Harkness","sequence":"additional","affiliation":[{"name":"Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester NHS Trust, Manchester, UK"},{"name":"The University of Manchester, Manchester Academic Health Science Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK"},{"name":"Centre for Imaging Sciences, University of Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Lalloo","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Central Manchester Foundation Trust, St. Mary's Hospital, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Howell","sequence":"additional","affiliation":[{"name":"Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester NHS Trust, Manchester, UK"},{"name":"Manchester Breast Centre, Manchester Cancer Research Centre, University of Manchester, Christie Hospital, Manchester, UK"},{"name":"The University of Manchester, Manchester Academic Health Science Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"2025101711301157000_51.9.573.1","doi-asserted-by":"publisher","DOI":"10.1086\/301749"},{"key":"2025101711301157000_51.9.573.2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.15.1310"},{"key":"2025101711301157000_51.9.573.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91578-4"},{"key":"2025101711301157000_51.9.573.4","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.14.1241"},{"key":"2025101711301157000_51.9.573.5","first-page":"741","article-title":"Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study","volume":"8","author":"Hopper","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025101711301157000_51.9.573.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.6772"},{"key":"2025101711301157000_51.9.573.7","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.16.1221"},{"key":"2025101711301157000_51.9.573.8","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-0517"},{"key":"2025101711301157000_51.9.573.9","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1907"},{"key":"2025101711301157000_51.9.573.10","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2785"},{"key":"2025101711301157000_51.9.573.11","doi-asserted-by":"publisher","DOI":"10.1126\/science.1088759"},{"key":"2025101711301157000_51.9.573.12","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj012"},{"key":"2025101711301157000_51.9.573.13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-155"},{"key":"2025101711301157000_51.9.573.14","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2013-101974"},{"key":"2025101711301157000_51.9.573.15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt095"},{"key":"2025101711301157000_51.9.573.16","doi-asserted-by":"publisher","DOI":"10.1038\/ng.586"},{"key":"2025101711301157000_51.9.573.17","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2008.062232"},{"key":"2025101711301157000_51.9.573.18","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12035"},{"key":"2025101711301157000_51.9.573.19","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2003.017996"},{"key":"2025101711301157000_51.9.573.20","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0138"},{"key":"2025101711301157000_51.9.573.21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.04.188"},{"key":"2025101711301157000_51.9.573.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012158"},{"key":"2025101711301157000_51.9.573.23","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-11-1196"},{"key":"2025101711301157000_51.9.573.24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003212"},{"key":"2025101711301157000_51.9.573.25","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604411"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2014-102336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T18:30:17Z","timestamp":1760725817000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2014-102336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,22]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,8,12]]},"published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1136\/jmedgenet-2014-102336"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2014-102336","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,22]]}}}